Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
DFUs arise from a multifactorial pathophysiology in which peripheral neuropathy reduces protective sensation and peripheral arterial disease compromises blood flow and tissue integrity
A Schedule 2 Controlled Drug
doi: 10.1002/sim.5705 48 AbadiASaadatSYavariPBajdikCJaliliP
By Product, the Pharmaceutical Grade segment is anticipated to witness the fastest growth, registering a CAGR of 5% over the forecast period By Application, the Healthcare Products segment accounted for the largest market share of 47.3% in 2018
This approach may offer rapid relief and promote healing at the site of the lesion
US$ 26.20
US$ 29.70
US$ 21.97
US$ 28.08
